USPTO 2015–2025 USPTO PatentsView US Corporation

Ande Corporation

USPTO PatentsView assignee record - 15 granted patents across 14 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

RSS updates for this company

The verdict

According to USPTO PatentsView, Ande ranks #18,381 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 14 technology areas.

#18,381
of 49,997 US assignees by volume
Top 43%
by Innovation Score (37.8/100)
18.7
avg claims per patent
+150%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18381 · US Corporation #18,381 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 15 grants
  • MID-PACK #18,381/49,997
  • PHOTO-FINISH Alzchem
  • CPC-FOCUS C12Q · 14 areas
  • INNOV-THIN 37.8/100
  • CLAIMS-RICH 18.7 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +150% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Alzchem AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ande’s 37.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Ande

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Ande's Innovation Score is 37.8/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Ande?

Each dot is one of Ande’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ande’s own 18.7 claims/patent is ABOVE the 16.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ande vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 14.914.91515.1 0102030 Granted patents (volume) Avg claims / patent Alzchem AG - 15, 21.4AlzchemAmcrest Global Holdings Limited - 15, 1Amcrest Global Ho…Amsel Medical Corporation - 15, 18Amsel MedicalAnchor Orthopedics XT Inc. - 15, 13.8Anchor Orthopedic…Ankobot (SHANGHAI) Smart Technologies Co., Ltd. - 15, 14.27Ankobot (Shanghai…Antaya Technologies Corporation - 15, 17.47AntayaAntonio Zamperla S.p.A. - 15, 16.13Antonio Zamperla…Apkudo, Inc. - 15, 25.07ApkudoAnde Corporation - 15, 18.67Ande
Ande vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ande's grants concentrate

Ande Corporation is a focused PatentsView assignee: 14 CPC subclasses with 86.7% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2017. By volume, Ande sits between Alzchem AG and Apkudo, Inc..

Ande's three-year grant acceleration

Ande Corporation shows 4 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Ande's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Ande holds 15 patents at rank #18,354, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Ande

By rank, the assignees closest to #18,354 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Ande's primary technology class.

Ande's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 201720182019202020212022202320242025 1
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Ande Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 6.7%
2018 2 13.3%
2019 1 6.7%
2020 2 13.3%
2021 4 26.7%
2022 1 6.7%
2023 2 13.3%
2024 1 6.7%
2025partial year 1 6.7%

Which technologies does Ande Corporation patent most?

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Ande Corporation's patent record in context - here's where to go next.

  • Ande Corporation's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 86.7% of its portfolio - see every assignee active in that class. Explore C12Q
  • Ranked #18,381 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Ande Corporation against Alzchem AG, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 37.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.